Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Antibiotics Can Cause Pervasive, Persistent Changes to the Microbial Community in the Human Gut, MBL and Stanford Scientists Report
Slashdot It! Slashdot Antibiotics Can Cause Pervasive, Persistent Changes to the Microbial Community in the Human Gut, MBL and Stanford Scientists Report
Submit to Reddit Submit Antibiotics Can Cause Pervasive, Persistent Changes to the Microbial Community in the Human Gut, MBL and Stanford Scientists Report to Reddit
Reading: Antibiotics Can Cause Pervasive, Persistent Changes to the Microbial Community in the Human Gut, MBL and Stanford Scientists ReportTwitter This Reading: Antibiotics Can Cause Pervasive, Persistent Changes to the Microbial Community in the Human Gut, MBL and Stanford Scientists ReportTwitter Antibiotics Can Cause Pervasive, Persistent Changes to the Microbial Community in the Human Gut, MBL and Stanford Scientists Report
Add to Facebook Add Antibiotics Can Cause Pervasive, Persistent Changes to the Microbial Community in the Human Gut, MBL and Stanford Scientists Report to Facebook

Antibiotics Can Cause Pervasive, Persistent Changes to the Microbial Community in the Human Gut, MBL and Stanford Scientists Report

November 19, 2008

Using a novel technique developed by Mitchell Sogin of the Marine Biological Laboratory (MBL) to identify different types of bacteria, scientists have completed the most precise survey to date of how microbial communities in the human gut respond to antibiotic treatment.

Sogin, director of the MBL's Josephine Bay Paul Center, and Susan Huse of the MBL, along with David Relman and Les Dethlefsen of Stanford University, identified pervasive changes in the gut microbial communities of three healthy humans after a five-day course of the antibiotic Ciprofloxacin. Their results are reported in the Nov. 18 issue of PloS Biology.




Using very conservative criteria, the scientists identified at least 3,300 to 5,700 different taxa (genetically distinct types) of bacteria in the human distal gut, and antibiotic treatment influenced the abundance of about a third of those taxa.

"You clearly get shifts in the structure of the microbial community with antibiotic treatment," says Sogin. "Some bacteria that were in low abundance prior to treatment may become more abundant, and bacteria that were dominant may decrease in abundance. When you get these shifts, they may be persistent. Some individuals may recover quickly, and others won't recover for many months."

In all the individuals tested in this study, the bacterial community recovered and closely resembled its pre-treatment state within four weeks after the antibiotic course ended, but several bacterial taxa failed to recover within six months.

This raises questions about the health effects of perturbations to the human-microbial symbiosis in the gut, such as may occur with antibiotic treatment. Because specific microbial populations mediate many chemical transformations in the gut-and previous studies have related these processes to cancer and obesity, among other conditions-changes in the composition of the gut microbiota could have important, but as yet undiscovered, health effects.

"When you change the microbial population structure in the gut, you may affect how that population is keeping indigenous pathogens at manageable levels," says Sogin. Bacteria that do not normally cause problems may begin to grow more rapidly, and cause disease.

The study is part of a large, international effort to fully characterize the microbiota in the human gut, which is the highest-density natural bacterial ecosystem known. Up to 100 trillion microbial cells reside in the gut, and this community plays essential roles in nutrition, development, metabolism, pathogen resistance, and regulation of immune responses.

Until recently, descriptions of human-associated microbiota were constrained by techniques of cultivating (and thus identifying) bacteria. Less than 20-40% of the microbes in the human distal gut, for example, have been cultured in the laboratory. Since the late 1980s, however, cultivation-independent microbial surveys have been developed that identify community members by genetic sequencing. Sogin's technique, for example, which was used in this study, characterizes microbial populations by pyrosequencing short, hypervariable regions of one gene common to all microbes, the 16S rRNA gene. This technique reveals greater taxonomic richness in microbial samples at a fraction of the cost of traditional sequencing technologies.

Marine Biological Laboratory





Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Heart Muscle   Calcium   Terrorism   Resveratrol   Earthquakes   Particle Physics   Solar Wind   Neuroblastoma   Metformin   Fishing   Fossil Fuel   Gestational Diabetes   Superconductors   Coral reef   Autoimmune Disease   Cardiac Surgery   Natural Selection   Butterflies   Cassini   Flavonoids   Brain Development   Neutron Star   Methylmercury   Peripheral Artery Disease   Venus Express  
Related Antibiotic Treatment Current Events and Antibiotic Treatment News Articles Antibiotic Treatment Current Events and Antibiotic Treatment News RSS Antibiotic Treatment Current Events and Antibiotic Treatment News RSS
Blood tests and better communication skills could cut over-prescribing of antibiotics
Improving communications skills and the use of a simple blood test could help cut the growing number of inappropriate prescriptions of antibiotics, a joint Cardiff University trial has discovered.

Slow-growing TB bacteria point the way to new drug development
The discovery of a large number of slow-growing Mycobacterium tuberculosis bacteria, which cause tuberculosis (TB), in the lungs of TB patients could be an important step forward in the design of new anti-TB drugs.

What makes C-Diff superbug deadly?
A major breakthrough about the potentially deadly superbug Clostridium difficile (C-diff) could lead to new ways to combat the bacterium, according to a study to be published March 1 in the journal Nature.

Helicobacter pylori can multiply in autophagic vesicles
Helicobacter pylori, a Gram-negative, flagellated, microaerophilic bacterium, can selectively colonize in the human stomach. Its infection is widespread throughout the world, and is present in about 50% of the global human population with 80% in developing countries and 20-50% in industrialized countries.

Understanding Extinct Microbes May Influence the State of Modern Human Health
The study of ancient microbes may not seem consequential, but such pioneering research at the University of Oklahoma has implications for the state of modern human health. Cecil Lewis, assistant professor in the Department of Anthropology, says results of this research raise questions about the microbes living on and within people.

'Zinc Zipper' Plays Key Role In Hospital-Acquired Infections
Hospital-acquired infections that are resistant to traditional antibiotic treatment have become increasingly common in recent years, confounding health care professionals and killing thousands of Americans.

Researchers identify new leprosy bacterium
A new species of bacterium that causes leprosy has been identified through intensive genetic analysis of a pair of lethal infections, a research team reports in the December issue of the American Journal of Clinical Pathology.

Biomedical engineers' detective work reveals antibiotic mechanism
A series of genetic clues led a team of Boston University biomedical engineers to uncover exactly how certain antibiotics kill bacteria. The findings could help rejuvenate the efficacy of older antibiotics and reveal new antibiotic targets within bacterial cells.

Researchers downplay MRSA screening as effective infection control intervention
Three Virginia Commonwealth University epidemiologists are downplaying the value of mandatory universal nasal screening of patients for MRSA, arguing that proven, hospital-wide infection control practices can prevent more of the potentially fatal infections.

Infectious heart disease death rates rising again say scientists
Infectious heart disease is still a major killer in spite of improvements in health care, but the way the disease develops has changed so much since its discovery that nineteenth century doctors would not recognize it.
More Antibiotic Treatment Current Events and Antibiotic Treatment News Articles
Manual of Antibiotics and Infectious Diseases: Treatment and Prevention

Manual of Antibiotics and Infectious Diseases: Treatment and Prevention
by John E Conte (Author)

Univ. of California, San Francisco. Manual designed for students, residents, and clinicians involved in the diagnosis, treatment, and prevention of infectious disease. Previous edition: c1995. Covers antibiotics, dosages, and recommendations. Softcover. DNLM: Antibiotics--therapeutic use--Handbooks.

First Aid Only Triple Antibiotic Ointment Pack, 0.5 Gram, 10-Count Boxes (Pack of 10)

First Aid Only Triple Antibiotic Ointment Pack, 0.5 Gram, 10-Count Boxes (Pack of 10)
by First Aid Only

Use this triple antibiotic ointment pack to treat all kinds of minor cuts, burns and abrasions. Helps prevent infection while it promotes healing. May be applied 2 to 3 times daily as the condition indicates. Active ingredients: neomycin and polymyxin B sulfates and bacitracin zinc ointment USP.

Pneumonia Before Antibiotics: Therapeutic Evolution and Evaluation in Twentieth-Century America

Pneumonia Before Antibiotics: Therapeutic Evolution and Evaluation in Twentieth-Century America
by The Johns Hopkins University Press

Pneumonia -- Osler's "Captain of the Men of Death" and still the leading infectious cause of death in the United States -- has until now received scant attention from historians. In Pneumonia Before Antibiotics, clinician-historian Scott H. Podolsky uses pneumonia's enduring prevalence and its centrality to the medical profession's therapeutic self-identity to examine the evolution of therapeutics in twentieth-century America.

Focusing largely on the treatment of pneumonia in first half of the century with type-specific serotherapy, Podolsky provides insight into the rise and clinical evaluation of therapeutic "specifics," the contested domains of private practice and public health, and-as the treatment of pneumonia made the transition from serotherapy to chemotherapy and...

Triple Antibiotic Ointment - 1 oz

Triple Antibiotic Ointment - 1 oz
by BUTLER SALES

An antibiotic ointment for use in the control and prevention of wound infections.

Conquering Sinusitis: New Frontiers in Diagnosis and Treatment

Conquering Sinusitis: New Frontiers in Diagnosis and Treatment

Sinusitis is one of the most common health conditions in the United States. It is estimated that more than 37 million people suffer from sinusitis and sinusitis related conditions annually. In this lecture, Dr. Peter Hwang reviews current concepts in the diagnosis and treatment of sinusitis, with an emphasis on recent innovations such as computerized surgical navigation and new drug delivery technologies.

Peter Hwang, M.D. is an associate professor of Otolaryngology at Stanford University Medical Center and Director of the Stanford Sinus Center. A noted national and international lecturer, Dr. Hwang also serves on the Board of Directors of the American Rhinologic Society and is Associate Editor of the American Journal of Rhinology.

This product is manufactured on demand using DVD-R...

Solving the Puzzling Problem of Arthritis: An Antibiotic Treatment Handbook for Patients and Doctors

Solving the Puzzling Problem of Arthritis: An Antibiotic Treatment Handbook for Patients and Doctors
by Pat Ganger and Carol Lange (Author)

An invaluable handbook for anyone who is using or plans to use antibiotic therapy for rheumatoid diseases.

  Local antibiotic treatment in osteomyelitis and soft-tissue infections: Proceedings of a symposium, Amsterdam, October 25, 1980 (International congress series)
b



  CD-ROM, Antibiotic Treatment Physician Toolkit: Physician and Patient Educational Resources
by Aetna



Neosporin Plus Pain Relief First Aid Antibiotic/Pain Relieving Cream, Maximum Strength 0.5-Ounce Tubes (Pack of 4)

Neosporin Plus Pain Relief First Aid Antibiotic/Pain Relieving Cream, Maximum Strength 0.5-Ounce Tubes (Pack of 4)
by Neosporin

This first-aid antibiotic and pain relief cream helps soothe painful cuts, scrapes and burns while preventing infection. Contains neomycin sulfate, polymyxin B sulfate, and pramoxine HCI. Maximum strength pain relief formula. Doctor-recommended brand.

  Holistic remedies for AOM prevention, treatment. (When Parents Reject Antibiotics).(acute otitis media)(Brief Article): An article from: Pediatric News
by Robert Finn (Author)

This digital document is an article from Pediatric News, published by International Medical News Group on April 1, 2002. The length of the article is 639 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Holistic remedies for AOM prevention, treatment. (When Parents Reject Antibiotics).(acute otitis media)(Brief Article)
Author: Robert Finn
Publication: Pediatric News (Magazine/Journal)
Date: April 1, 2002
Publisher: International Medical News Group
Volume: 36 Issue: 4 Page: 24(1)

Article Type: Brief Article

Distributed by Thomson...

© 2009 BrightSurf.com